AH Equity Partners Bio II, L.L.C. - Q4 2021 holdings

$192 Million is the total value of AH Equity Partners Bio II, L.L.C.'s 4 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .

 Value Shares↓ Weighting
NewEQRx, Inc.$118,930,00017,438,465
+100.0%
61.93%
NewErasca, Inc.$38,950,0002,500,000
+100.0%
20.28%
NVTA NewInVitae Corporation$17,868,0001,170,127
+100.0%
9.30%
NAUT NewNautilus Biotechnology, Inc.$16,298,00016,298,006
+100.0%
8.49%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
EQRx, Inc.4Q3 202261.9%
Nautilus Biotechnology, Inc.4Q3 202240.8%
Erasca, Inc.4Q3 202220.3%
InVitae Corporation4Q3 20229.3%

View AH Equity Partners Bio II, L.L.C.'s complete holdings history.

Latest filings
TypeFiled
42023-11-09
42023-01-04
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
32021-12-22
32021-06-09

View AH Equity Partners Bio II, L.L.C.'s complete filings history.

Export AH Equity Partners Bio II, L.L.C.'s holdings